Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats

Behavioural Brain Research

Volumn 205, Issue 1, 2009, Pages 214-218

  Jia, Jun ^a   Sun, ZuoLi ^a   Li, Bo ^a   Pan, YanLi ^a   Wang, HaoMin ^a   Wang, Xuan ^a   Yu, Fen ^a   Liu, LiMin ^a   Zhang, LiJuan ^a   Wang, XiaoMin ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Basal ganglia circuit; Electro acupuncture; GABA; Parkinson's disease; Substance P

Indexed keywords

APOMORPHINE; ENKEPHALIN; GLUTAMATE DECARBOXYLASE 67; MESSENGER RNA; SUBSTANCE P; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN LEVEL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; ELECTROACUPUNCTURE; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; MALE; MEDIAL FOREBRAIN BUNDLE; MOTOR DYSFUNCTION; NERVE DEGENERATION; NERVE FIBER TRANSECTION; NEUROPROTECTION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; ROTATION; SUBSTANTIA NIGRA; THERAPY EFFECT;

ANIMALS; ANTIPARKINSON AGENTS; APOMORPHINE; BRAIN; DISEASE MODELS, ANIMAL; DOPAMINE; DYSKINESIAS; ELECTROACUPUNCTURE; ENKEPHALINS; GLUTAMATE DECARBOXYLASE; MALE; MEDIAL FOREBRAIN BUNDLE; MOTOR ACTIVITY; NEURONS; PARKINSONIAN DISORDERS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RNA, MESSENGER; SUBSTANCE P; TYROSINE 3-MONOOXYGENASE;

EID: 70349293632     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.06.024     Document Type: Article

References (31)

1. Rabinstein A.A., and Shulman L.M. Acupuncture in clinical neurology. Neurologist 9 (2003) 137-148
2. Shulman L.M., Wen X., Weiner W.J., Bateman D., Minagar A., Duncan R., et al. Acupuncture therapy for the symptoms of Parkinson's disease. Mov Disord 17 (2002) 799-802
3. Liang X.B., Luo Y., Liu X.Y., Lu J., Li F.Q., Wang Q., et al. Electro-acupuncture improves behavior and upregulates GDNF mRNA in MFB transected rats. Neuroreport 14 (2003) 1177-1181
4. Liang X.B., Liu X.Y., Li F.Q., Luo Y., Lu J., Zhang W.M., et al. Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Brain Res Mol Brain Res 108 (2002) 51-59
5. Blandini F., Nappi G., Tassorelli C., and Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol 62 (2000) 63-88
6. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989) 366-375
7. Alexander G.E., Crutcher M.D., and DeLong M.R. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 85 (1990) 119-146
8. Alexander G.E., and Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13 (1990) 266-271
9. Tseng J.L., Baetge E.E., Zurn A.D., and Aebischer P. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J Neurosci 17 (1997) 325-333
10. Park H.J., Lim S., Joo W.S., Yin C.S., Lee H.S., Lee H.J., et al. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. Exp Neurol 180 (2003) 93-98
11. Kim Y.K., Lim H.H., Song Y.K., Lee H.H., Lim S., Han S.M., et al. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats. Neurosci Lett 384 (2005) 133-138
12. Weiser M., Baker H., Wessel T.C., and Joh T.H. Axotomy-induced differential gene induction in neurons of the locus ceruleus and substantia nigra. Brain Res Mol Brain Res 17 (1993) 319-327
13. Brecknell J.E., Dunnett S.B., and Fawcett J.W. A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle. Neuroscience 64 (1995) 219-227
14. Knusel B., Beck K.D., Winslow J.W., Rosenthal A., Burton L.E., Widmer H.R., et al. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 12 (1992) 4391-4402
15. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., et al. Functional recovery in Parkinsonian monkeys treated with GDNF. Nature 380 (1996) 252-255
16. Robertson G.S., and Robertson H.A. Evidence that l-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J Neurosci 9 (1989) 3326-3331
17. Cheramy A., Leviel V., and Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature 289 (1981) 537-542
18. Liu X.Y., Zhou H.F., Pan Y.L., Liang X.B., Niu D.B., Xue B., et al. Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats. Exp Neurol 189 (2004) 189-196
19. Hatzipetros T., and Yamamoto B.K. Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra. Brain Res 1076 (2006) 60-67
20. Chen Y.I., Ren J., Wang F.N., Xu H., Mandeville J.B., Kim Y., et al. Inhibition of stimulated dopamine release and hemodynamic response in the brain through electrical stimulation of rat forepaw. Neurosci Lett 431 (2008) 231-235
21. Zangen A., and Hyodo K. Transcranial magnetic stimulation induces increases in extracellular levels of dopamine and glutamate in the nucleus accumbens. Neuroreport 13 (2002) 2401-2405
22. Strafella A.P., Paus T., Barrett J., and Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 21 (2001) RC157
23. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma Jr. F.J., et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
24. Hasenöhrl R.U., Souza-Silva M.A., Nikolaus S., Tomaz C., Brandao M.L., Schwarting R.K., et al. Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 34 (2000) 272-280
25. Mattioli R., Schwarting R.K., and Huston J.P. Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P 1-11. Neuroscience 48 (1992) 595-605
26. Nikolaus S., Huston J.P., Körber B., Thiel C., and Schwarting R.K. Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion. Peptides 18 (1997) 1161-1168
27. Nikolaus S., Huston J.P., and Schwarting R.K. Pretreatment with fragments of substance-P or with cholecystokinin differentially affects recovery from sub-total nigrostriatal 6-hydroxydopamine lesion. Neural Plast 6 (1999) 77-89
28. Zetterstrom T., Sharp T., Marsden C.A., and Ungerstedt U. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J Neurochem 41 (1983) 1769-1773
29. Levy R., Ashby P., Hutchison W.D., Lang A.E., Lozano A.M., and Dostrovsky J.O. Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease. Brain 125 (2002) 1196-1209
30. Guridi J., Herrero M.T., Luquin M.R., Guillen J., Ruberg M., Laguna J., et al. Subthalamotomy in Parkinsonian monkeys. Behavioural and biochemical analysis. Brain 119 Pt 5 (1996) 1717-1727
31. Salin P., Manrique C., Forni C., and Kerkerian-Le G.L. High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. J Neurosci 22 (2002) 5137-5148